When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
It hasn't been a great year to hold shares of somewhat speculative and unprofitable stocks. Gene-editing specialist Editas Medicine (NASDAQ: EDIT) fits the bill, which is why the company's shares have plunged this year. But things can change quickly in the volatile biotech industry.
Within 12 months, a company can score meaningful clinical or regulatory wins that send its stock price soaring. Could this be what's in store for Editas Medicine in the next year? Let's dig into the company's business to find out.